Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Vrentas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annual Review of Microbiology|July 22, 2015
Anthrax PathogenesisMahtab Moayeri, Stephen H Leppla, Catherine Vrentas, et al.
G3 (Bethesda, Md.)|March 1, 2020
Genome Report-A Genome Sequence Analysis of the RB51 Strain of <i>Brucella abortus</i> in the Context of Its Vaccine PropertiesBetsy Bricker, Nalin Goonesekere, Darrell Bayles, et al.
Scientific Reports|February 22, 2020
Novel Strain of the Chronic Wasting Disease Agent Isolated From Experimentally Inoculated Elk With LL132 Prion ProteinJo Moore, Trudy Tatum, Soyoun Hwang, et al.
The Journal of Biological Chemistry|January 8, 2015
A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge modelMahtab Moayeri, Clinton E Leysath, Jacqueline M Tremblay, et al.
Protein Science : a Publication of the Protein Society|August 15, 2015
Hfqs in Bacillus anthracis: Role of protein sequence variation in the structure and function of proteins in the Hfq familyCatherine Vrentas, Rodolfo Ghirlando, Andrea Keefer, et al.
The AAPS Journal|August 23, 2024
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker AssessmentMitra Azadeh, Jeremy Good, Michele Gunsior, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosisKaren J Quadrini, Catherine Vrentas, Christian Duke, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annual Review of Microbiology|July 22, 2015
Anthrax PathogenesisMahtab Moayeri, Stephen H Leppla, Catherine Vrentas, et al.
G3 (Bethesda, Md.)|March 1, 2020
Genome Report-A Genome Sequence Analysis of the RB51 Strain of <i>Brucella abortus</i> in the Context of Its Vaccine PropertiesBetsy Bricker, Nalin Goonesekere, Darrell Bayles, et al.
Scientific Reports|February 22, 2020
Novel Strain of the Chronic Wasting Disease Agent Isolated From Experimentally Inoculated Elk With LL132 Prion ProteinJo Moore, Trudy Tatum, Soyoun Hwang, et al.
The Journal of Biological Chemistry|January 8, 2015
A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge modelMahtab Moayeri, Clinton E Leysath, Jacqueline M Tremblay, et al.
Protein Science : a Publication of the Protein Society|August 15, 2015
Hfqs in Bacillus anthracis: Role of protein sequence variation in the structure and function of proteins in the Hfq familyCatherine Vrentas, Rodolfo Ghirlando, Andrea Keefer, et al.
The AAPS Journal|August 23, 2024
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker AssessmentMitra Azadeh, Jeremy Good, Michele Gunsior, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosisKaren J Quadrini, Catherine Vrentas, Christian Duke, et al.
Pageof 1